Although recent work has described the microbiome in solid tumors, microbial content in hematological malignancies is not well-characterized. Here we analyze existing deep DNA sequence data from the blood and bone marrow of 1870 patients with myeloid malignancies, along with healthy controls, for bacterial, fungal, and viral content. After strict quality filtering, we find evidence for dysbiosis in disease cases, and distinct microbial signatures among disease subtypes. We also find that microbial content is associated with host gene mutations and with myeloblast cell percentages. In patients with low-risk myelodysplastic syndrome, we provide evidence that Epstein-Barr virus status refines risk stratification into more precise categories than the current standard. Motivated by these observations, we construct machine-learning classifiers that can discriminate among disease subtypes based solely on bacterial content. Our study highlights the association between the circulating microbiome and patient outcome, and its relationship with disease subtype.

Woerner, J., Huang, Y., Hutter, S., Gurnari, C., Sánchez, J., Wang, J., et al. (2022). Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes. NATURE COMMUNICATIONS, 13(1), 1-13 [10.1038/s41467-022-28678-x].

Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes

Gurnari, Carmelo
Formal Analysis
;
2022-02-24

Abstract

Although recent work has described the microbiome in solid tumors, microbial content in hematological malignancies is not well-characterized. Here we analyze existing deep DNA sequence data from the blood and bone marrow of 1870 patients with myeloid malignancies, along with healthy controls, for bacterial, fungal, and viral content. After strict quality filtering, we find evidence for dysbiosis in disease cases, and distinct microbial signatures among disease subtypes. We also find that microbial content is associated with host gene mutations and with myeloblast cell percentages. In patients with low-risk myelodysplastic syndrome, we provide evidence that Epstein-Barr virus status refines risk stratification into more precise categories than the current standard. Motivated by these observations, we construct machine-learning classifiers that can discriminate among disease subtypes based solely on bacterial content. Our study highlights the association between the circulating microbiome and patient outcome, and its relationship with disease subtype.
24-feb-2022
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/15 - MALATTIE DEL SANGUE
English
Woerner, J., Huang, Y., Hutter, S., Gurnari, C., Sánchez, J., Wang, J., et al. (2022). Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes. NATURE COMMUNICATIONS, 13(1), 1-13 [10.1038/s41467-022-28678-x].
Woerner, J; Huang, Y; Hutter, S; Gurnari, C; Sánchez, Jmh; Wang, J; Huang, Y; Schnabel, D; Aaby, M; Xu, W; Thorat, V; Jiang, D; Jha, Bk; Koyuturk, M; Maciejewski, Jp; Haferlach, T; Laframboise, T
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
s41467-022-28678-x.pdf

accesso aperto

Licenza: Copyright dell'editore
Dimensione 4.03 MB
Formato Adobe PDF
4.03 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/311867
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 13
social impact